New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2014
09:35 EDTPODDInsulet price target raised to $43 from $35 at Stephens
Stephens raised its price target on Insulet to $43 following the company's Q4 report and FY14 guidance, but says it views the shares as fairly valued and maintains its Equal Weight rating on the stock.
News For PODD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
09:26 EDTPODDLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy assesses the rapidly-evolving diabetes landscape and the potential growth trajectory for Insulet's OmniPod and DexCom's CGM on an Analyst/Industry conference call to be held on January 29 at 2 pm.
January 26, 2015
10:00 EDTPODDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:53 EDTPODDInsulet downgraded to Market Perform from Outperform at William Blair
William Blair downgraded Insulet to Market Perform citing weaker domestic insulin pump market trends.
January 21, 2015
07:31 EDTPODDInsulet well positioned to beat expectations, says Leerink
Leerink believes the worst is now behind Insulet and that the company is positioned for accelerating new patient adds in Q2 and beyond. Leerink thinks lowered base expectations position Insulet to potentially top forecasts in 2015. The firm lowered its price target for shares to $40 and $50 and keeps an Outperform rating on the name.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use